Annexon Biosciences's market cap is currently $327.24M. The company's EPS TTM is $-1.038; its P/E ratio is ―; Annexon Biosciences is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -3.27M	$ -3.31M	$ -3.41M	$ -667.00K	$ -493.00K
Operating Income	$ -143.72M	$ -145.60M	$ -130.71M	$ -63.47M	$ -32.52M
EBITDA	$ -141.57M	$ -143.49M	$ -128.57M	$ -62.80M	$ -32.02M
Net Income	$ -134.24M	$ -138.29M	$ -127.79M	$ -62.74M	$ -37.18M
Balance Sheet
Cash & Short-Term Investments	$ 259.72M	$ 242.66M	$ 242.72M	$ 351.21M	$ 43.93M
Total Assets	$ 297.67M	$ 285.10M	$ 287.04M	$ 355.95M	$ 49.90M
Total Debt	$ 31.36M	$ 32.86M	$ 34.59M	$ 0.00	$ 0.00
Net Debt	$ -193.75M	$ -107.16M	$ -40.25M	$ -268.56M	$ -43.93M
Total Liabilities	$ 47.12M	$ 53.90M	$ 55.13M	$ 11.67M	$ 6.37M
Stockholders' Equity	$ 250.56M	$ 231.19M	$ 231.91M	$ 344.28M	$ 43.53M
Cash Flow
Free Cash Flow	$ -121.33M	$ -122.83M	$ -107.76M	$ -53.55M	$ -28.63M
Operating Cash Flow	$ -121.14M	$ -116.31M	$ -106.11M	$ -53.09M	$ -28.36M
Investing Cash Flow	$ 70.70M	$ 58.44M	$ -88.24M	$ -83.16M	$ -267.00K
Financing Cash Flow	$ 135.52M	$ 122.91M	$ 1.79M	$ 360.88M	$ 28.39M

Currency in USD

Annexon Biosciences Earnings and Revenue History

Income Statement >

Annexon Biosciences Debt to Assets

Balance Sheet >

Annexon Biosciences Cash Flow

Cash Flow >

Annexon Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing